🇺🇸 FDA
Patent

US 12251379

Methods of inhibiting formation of alpha synuclein aggregates

granted A61KA61K31/198A61K31/202

Quick answer

US patent 12251379 (Methods of inhibiting formation of alpha synuclein aggregates) held by The Regents of the University of California expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/198, A61K31/202, A61K31/375, A61K31/415